Sarah Byford1. 1. King's College London, Centre for the Economics of Mental and Physical Health, London, United Kingdom. s.byford@kcl.ac.uk
Abstract
BACKGROUND: Despite a preference for economic evaluations to measure outcomes in terms of quality-adjusted life years, generic measures of outcome are rarely used in mental health research involving young people. AIMS: To explore the validity and responsiveness of the EQ-5D measure of health-related quality of life in adolescents with major depression. METHOD: Data came from a clinical trial involving adolescents with persistent major depression (n = 199). Construct validity was tested using socio-demographic constructs and baseline clinical outcome scores. To assess convergent validity, correlation between EQ-5D and clinical outcome scores was tested. To assess responsiveness, the mean change in EQ-5D scores of participants categorised as improved versus not improved on clinical outcome measures was tested. RESULTS: Significant differences in mean EQ-5D score were found for co-morbidity and three of four severity measures but not gender, age, treatment history or suicide attempts. Mean EQ-5D scores were significantly correlated with all clinical outcome measures, although relationships were moderate or weak. A change in mean EQ-5D score was significantly related to clinical assessments of improvement on all outcome measures. CONCLUSIONS: Results provide initial evidence to support the relevance of the EQ-5D in adolescents with major depression, but this evidence is weak. Replication studies are needed to assess the generalisability of these findings.
RCT Entities:
BACKGROUND: Despite a preference for economic evaluations to measure outcomes in terms of quality-adjusted life years, generic measures of outcome are rarely used in mental health research involving young people. AIMS: To explore the validity and responsiveness of the EQ-5D measure of health-related quality of life in adolescents with major depression. METHOD: Data came from a clinical trial involving adolescents with persistent major depression (n = 199). Construct validity was tested using socio-demographic constructs and baseline clinical outcome scores. To assess convergent validity, correlation between EQ-5D and clinical outcome scores was tested. To assess responsiveness, the mean change in EQ-5D scores of participants categorised as improved versus not improved on clinical outcome measures was tested. RESULTS: Significant differences in mean EQ-5D score were found for co-morbidity and three of four severity measures but not gender, age, treatment history or suicide attempts. Mean EQ-5D scores were significantly correlated with all clinical outcome measures, although relationships were moderate or weak. A change in mean EQ-5D score was significantly related to clinical assessments of improvement on all outcome measures. CONCLUSIONS: Results provide initial evidence to support the relevance of the EQ-5D in adolescents with major depression, but this evidence is weak. Replication studies are needed to assess the generalisability of these findings.
Authors: Peter Fonagy; Stephen Butler; David Cottrell; Stephen Scott; Stephen Pilling; Ivan Eisler; Peter Fuggle; Abdullah Kraam; Sarah Byford; James Wason; Rachel Ellison; Elizabeth Simes; Poushali Ganguli; Elizabeth Allison; Ian M Goodyer Journal: Lancet Psychiatry Date: 2018-01-05 Impact factor: 27.083
Authors: John F Dickerson; David H Feeny; Gregory N Clarke; Alex L MacMillan; Frances L Lynch Journal: Qual Life Res Date: 2017-11-17 Impact factor: 4.147
Authors: Tim Carter; Boliang Guo; David Turner; Ioannis Morres; Elizabeth Khalil; Emily Brighton; Marie Armstrong; Patrick Callaghan Journal: BMC Psychiatry Date: 2015-10-14 Impact factor: 3.630
Authors: Ian M Goodyer; Shirley Reynolds; Barbara Barrett; Sarah Byford; Bernadka Dubicka; Jonathan Hill; Fiona Holland; Raphael Kelvin; Nick Midgley; Chris Roberts; Rob Senior; Mary Target; Barry Widmer; Paul Wilkinson; Peter Fonagy Journal: Lancet Psychiatry Date: 2016-12-01 Impact factor: 27.083
Authors: Willem Kuyken; Elizabeth Nuthall; Sarah Byford; Catherine Crane; Tim Dalgleish; Tamsin Ford; Mark T Greenberg; Obioha C Ukoumunne; Russell M Viner; J Mark G Williams Journal: Trials Date: 2017-04-26 Impact factor: 2.279
Authors: Mimmi Åström; Sonja Krig; Sara Ryding; Neil Cleland; Ola Rolfson; Kristina Burström Journal: Health Qual Life Outcomes Date: 2020-06-03 Impact factor: 3.186
Authors: Jochen O Mierau; Daphne Kann-Weedage; Pieter J Hoekstra; Lisan Spiegelaar; Danielle E M C Jansen; Karin M Vermeulen; Sijmen A Reijneveld; Barbara J van den Hoofdakker; Erik Buskens; M Elske van den Akker-van Marle; Carmen D Dirksen; Annabeth P Groenman Journal: BMC Pediatr Date: 2020-07-03 Impact factor: 2.125